Upregulation of CHEK1 is involved in various types of cancer and promotes tumor progression via affecting cell cycle and DNA damage response including breast cancer, pancreatic cancer, and oral squamous cell carcinoma [64]. Here, CHEK1 is linked to pancreatic neoplasm.